Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
US Judge Dismisses Gautam Adani Criminal Charges 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Airbus Joins Air India A320 Altitude Drop Probe 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges 
Dutch healthcare technology giant Philips (EPA:TTEF) forecasted a 1% to 3% increase in comparable sales for 2025 despite ongoing challenges in China. The company missed market expectations for Q4 2024, reporting €5.04 billion ($5.27 billion) in revenue, slightly below analysts’ projections of €5.07 billion.
Philips attributed the weaker performance to a double-digit decline in China sales, which is expected to continue in 2025. The forecast includes a mid- to high-single-digit drop in Chinese revenue and the impact of new U.S.-China tariffs. CEO Roy Jakobs previously stated that China’s contribution to total revenue has fallen to around 10%, down from over 13% earlier in the decade. The company employs over 7,000 people in the country.
Despite the decline, Philips maintained its commitment to growth, with adjusted EBITA reaching €679 million for Q4, slightly below the €683 million analysts expected. The company proposed an annual dividend of €0.85 per share, consistent with the previous year.
Philips, known for its diverse portfolio from medical imaging systems to consumer electronics, had already lowered its 2024 sales forecast in October due to weak demand in China. The company’s ability to navigate global economic shifts, supply chain disruptions, and geopolitical challenges will be critical for its 2025 performance.
With a focus on stabilizing sales and overcoming market headwinds, Philips continues to adapt its strategy amid evolving economic conditions.
